Related Experiment Videos

DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation

T Raveh1, G Droguett, M S Horwitz

  • 1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.

Nature Cell Biology
|January 9, 2001
PubMed

Insights

Death-associated protein (DAP) kinase suppresses cancer by activating the p19ARF/p53 apoptotic pathway. Loss of DAP kinase function weakens this crucial checkpoint, allowing pre-malignant cells to survive.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Death Pathways

Background:

  • DAP kinase, a calcium-regulated serine/threonine kinase, is often downregulated in human tumors.
  • Loss of DAP kinase expression is linked to cancer development.

Purpose of the Study:

  • To investigate the role of DAP kinase in counteracting oncogene-induced transformation.
  • To elucidate the mechanism by which DAP kinase influences the p19ARF/p53 apoptotic pathway.

Main Methods:

  • Ectopic expression of DAP kinase in primary embryonic fibroblasts.
  • Analysis of p53 activation, caspase activation, and DNA fragmentation.
  • Investigating endogenous DAP kinase levels in response to oncogenes c-Myc and E2F-1.
  • Functional and genetic inactivation of DAP kinase.

Main Results:

  • Ectopic DAP kinase expression suppressed oncogenic transformation by inducing p53 in a p19ARF-dependent manner.
  • Fibroblasts expressing DAP kinase underwent apoptosis.
  • Endogenous DAP kinase was upregulated by c-Myc and E2F-1.
  • DAP kinase inactivation diminished p19ARF/p53 induction and apoptotic responses.

Conclusions:

  • DAP kinase acts as a tumor suppressor by activating an early apoptotic checkpoint.
  • This checkpoint eliminates pre-malignant cells through the p19ARF/p53 pathway.
  • DAP kinase plays a critical role in preventing cancer development.

Related Concept Videos